A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2

Sexually Transmitted Infections

Volumn 81, Issue 2, 2005, Pages 103-107

  Looker, K J ^a,b   Garnett, G P ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CLINICAL TRIAL; EPIDEMIOLOGICAL DATA; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION RISK; META ANALYSIS; NEWBORN; POPULATION RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; UNITED STATES; VIRUS CELL INTERACTION; VIRUS INFECTION;

HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; ODDS RATIO; PREVALENCE;

EID: 17144378952     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2004.012039     Document Type: Review

References (37)

1. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and - sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990;69:19-36.
2. Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-9.
3. Lawhagen GB, Tunback P, Bergstrom T. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol 2002;82:118-20.
4. Lafferly WE, Downey L, Celum C, et al. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181:1454-7.
5. Strutt M, Bailey J, Tenant-Flowers M, et al. Ethnic variation in type of genital herpes simplex virus infection in a South London genitourinary medicine clinic. J Med Virol 2003;69:108-10.
6. Scoular A, Norrie J, Gillespie G, et al. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 2002;324:1366-7.
7. Christie SN, McCaughey C, McBride M, et al. Herpes simplex type 1 and genital herpes in Northern Ireland. Int J STD AIDS 1997;8:68-9.
8. Wald A, Zeh J, Selke S, et al. Genital shedding of herpes simplex virus among men. J Infect Dis 2002;186(Suppl 1):S34-9.
9. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9.
10. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
11. Stanberry LR, Spruance SL, Cunningnam AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002;347:1652-61.
12. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999;12:1-8.
13. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1):S3-28.
14. Said SM, Alyan ZA. Seroprevalence of herpes simplex and varicella zoster virus among diabetic and non-diabetic patients with acute peripheral facial palsy. Neurosciences 2003;8:30-3.
15. Mihret W, Rinke de Wit TF, Petros B, et al. Herpes simplex virus type 2 seropositivity among urban adults in Africa: results from two cross-sectional surveys in Addis Ababa, Ethiopia. Sex Transm Dis 2002;29:175-81.
16. Howard M, Sellors JW, Jang D, et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 2003;41:84-9.
17. Stover CT, Smith DK, Schmid DS, et al. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis 2003;187:1388-96.
18. Wutzler P, Doerr HW, Farber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 2000;61:201-7.
19. Rabenau HF, Buxbaum S, Preiser W, et al. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol (Berl) 2002;190:153-60.
20. Robinson LG, Black FL, Lee FK, et al. Helicobacter pylori prevalence among indigenous peoples of South America. J Infect Dis 2002;186:1131-7.
21. Eis-Hubinger AM, Nyankiye E, Bitoungui DM, et al. Prevalence of herpes simplex virus type 2 antibody in Cameroon. Sex Transm Dis 2002;29:637-42.
22. Hashido M, Lee FK, Nahmias AJ, et al. An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect 1998;120:179-86.
23. Madhavan HN, Priya K. The diagnostic significance of enzyme linked immuno-sorbent assay for herpes simplex, varicella zoster and cytomegalovirus retinitis. Indian J Ophthalmol 2003;51:71-5.
24. Becker TM, Magder L, Harrison HR, et al. The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidemiol 1988;127:1071-8.
25. Cowan FM, Johnson AM, Ashley R, et al. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
26. Enders G, Risse B, Zauke M, et al. Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay. Eur J Clin Microbiol Infect Dis 1998;17:870-2.
27. Opaneye AA, Bashford J. Seroprevalence of antibodies to herpes simplex virus types 1 and 2 among two sexually active female populations in Middlesbrough, England. J R Soc Health 2002;122:108-11.
28. Kjaer SK, de Villiers EM, Haugaard BJ, et al. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer 1988;41:518-24.
29. Egger M, Davey Smith G, Altman DG. Systematic reviews in health care: meta-analysis in context, 2nd ed. London: BMJ Publishing Group, 2001.
30. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341:1432-8.
31. Stonberry LR, Cunningham AL, Mindel A, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000;30:549-66.
32. Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002;185:1019-24.
33. Hitti J, Watts DH, Burchett SK, et al. Herpes simplex virus serapositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 1997;177:450-4.
34. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
35. Ashley RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect 2001;77:232-7.
36. Cowan FM, French RS, Mayaud P, et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect 2003;79:286-90.
37. Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004;80:185-91.